Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung…
Roche announced US Food and Drug Administration (FDA) approval of the VENTANA ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC)…
Read More...
Read More...